1/66
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Range of Hgb
males 14-18
females 12-16
Range of Hct
males 42-52%
females 37-47%
Range of MCV
80-100
Range of MCH
30-34
Range of MCHC
31-37
Range of WBC
5-10 K/uL
Range of platelets
150,000-450,000 uL
MCV <80
LITS= lead poisoning, iron deficiency, thalassemia, sideroblastic (for this class, cram Pance is different)
Microcytic Anemia
most common cause of anemia
blood loss is most common cause
microcytic, hypochromic
Patho: low iron = low RBC production
Labs: dec MCV, MCH, low iron, low ferritin, high transferrin, low TIBC saturation
Tx: iron supplementation
Iron Deficiency Anemia
Patho: abn globin → hemolysis
Mediterranean, Africa, Asia (where malaria is)
Smear: stippled, target, elliptical cells
Labs: low MCV, low MCH, normal iron studies
Dx: use Hgb Electrophoresis (inc HbA2, HbF, HbH)
Tx: minor= no tx; major: transfusion, iron chelating, folate supplementation, splenectomy
Thalassemia (general)
4 genes
1 deletion: asymptomatic
2 deletions: mild anemia
3 deletions: severe anemia (transfusion dependent)
4 deletions: hydrops fetalis (die)
Alpha- Thalassemia
more common
2 genes
1-Beta Thalassemia Minor: mild anemia, asymptomatic
2-Beta Thalassemia Major: severe anemia, frontal bossing, hair on end skull X-ray, extra medullary hematopoesis
Beta-Thalassemia
microcytic, hypochromic
basophilic stippling
vague sx
Labs: above 10 mcg/dl is toxic
Tx: chelation, supportive care
Lead Poisoning Anemia
accelerated destruction
extravascular (damage, immune response)
intravascular (TTP, G6PD, Thalassemia, hereditary spherocytosis)
Labs: inc Bilirubin, inc LDH, dec Haptoglobin, high inc in reticulocytes
Hemolytic Anemia
MCV 80-100
analyze reticulocyte count → problem
elevated: blood loss, AIHA, G6PD
normal/low: chronic disease, CKD, BMF, myelofibrosis
Normocytic anemia
Chronic
microcytic, small bleeds, slow development
Acute
large volume loss, quick onset, high inc in reticulocytes, normocytic
Anemia of Blood Loss
most common RBC enzyme defect
X-linked recessive = males
sx under oxidative stress
stress → hemolysis
infection = most common stressor
Labs: normal MCV
Smear: Heinz bodies, bite cells
Tx: supportive, tx underlying cause, acute: transfusion
“stress makes me eat bites of fries w/ Heinz ketchup”
G6PD Deficiency
antibodies and complement destroy RBCs
Warm: IgG, most common
Cold: IgM
I’m always cold
Autoimmune Hemolytic Anemia (AIHA) -general
idiopathic, 2o to malignancy, virus, drugs, immunodeficiency
asymptomatic, anemia, jaundice, splenomegaly
Labs: inc LDH, inc reticulocytes, inc bilirubin, low hapto
Coombs (DAT)= +
Anti-C3= +
Tx: corticosteroids, folic acid
Warm AIHA
Chronic: older, more common
Acute: rare, self-limiting
Labs: inc LDH, inc reticulocytes, inc bilirubin, low hapto
RBC agglutination
DAT= + for C3 only
Cold agglutination = +
Tx: supportive measures
Cold AIHA
most common cause of normocytic anemia
malignancy, RA, CKD, IBD, DM
results from dec RBC production
Labs: dec reticulocyte count, low iron, high ferritin, low TIBC
Tx: underlying cause, Severe, EPO supplementation
Anemia of Chronic Disease
results from low EPO
Smear: burr cells
Labs: normal ferritin, low EPO, low iron, low transferrin
Tx: EPO injections
Anemia of CKD
inadequate blood cell production → low RBC, potentially low WBCs and plts
acquired or congenital
Ex: aplastic anemia
Bone Marrow Failure Syndromes
pancytopenia: anemia, thrombocytopenia, neutropenia
autoimmune attack on stem cells
dec plt production
Dx: bone marrow biopsy
Tx: refer to hemat, transfusions, immunosuppression
Aplastic anemia
colonial disorder: fibrotic tissue replaces bone marrow
extra medullary hematopoiesis
Pancytopenia
Tx: JAK2 inhibition, stem cell transplant
Myelofibrosis
MCV >100
Megaloblastic - hypersegmented neutrophils
B12 deficiency
Folate deficinecy
Non megaloblastic -no hypersegmentation
MDS
Macrocytic Anemia
folate deficiency is the most common cause
B12 is less common
Dx: macrocytosis, hypersegment neutrophils, Howell-Jolly
shilling’s test = checks b12 uptake
Megaloblastic Anemia
__ is needed for the formation of normal RBCs
animal products
can take yrs to deplete stores (chronic)
pernicious anemia is a common cause
PA= lack of intrinsic factor
Sx: neurological signs
Dx: inc MCV, inc homocysteine, inc MMA
Tx: ___ PO or IM
B12 deficiency
__ cofactor in DNA synthesis
2-3 month supply
leafy greens
due to inadequate intake
deficit in alcoholics, pregnancy
Labs: high MCV, low folic acid, inc homocysteine, MMA normal
Tx: oral supplements
Folate Deficiency
ineffective hematopoesis
pancytopenia w/ macrocytic anemia
low reticulocytes
→ AML
bone biopsy needed
Tx: growth factors, stem cell transplant
Myelodysplastic Syndrome
defect in Hgb
quantitative = Thalassemia
qualitative= Sickle Cell
defect in synthesis of heme= porphyias
Hemoglobinopathies
autosomal recessive; African Americans more common
defect on chromosome 11 → mutation of beta chain: HgB → HgS
SS, SC, Sickle-B thalassemia
HgS→ less soluble
can cause hemolytic anemia
Dx: Hgb Electrophoresis
Labs: dec H&H, inc WBCs, sickle cells, target cells, Howell-Jolly
pain crisis, acute chest syndrome
Tx: ER= transfusion or correct pain crisis event
Hydroxurea, stem cell transplant
Sickle Cell Disease
acquired, EPO disorder (MDS)
accumulation of iron → ringed sideroblasts
Labs: low MCV, inc iron, inc ferritin, low TIBC
Tx: transfusion, avoid offending toxin, bone marrow transplant
Sideroblastic Anemia
altered activity of 1/8 enzymes involved in heme biosynthesis
RARE
no cure
severe photosensitivity (avoid sun)
3 types: acute, blistering, non-blistering
Tx acute with Hemin
Porphyrias
most common in adults
changes of sun-exposed skin
blistering
measure plasma or urine porphyrins
Porphyria Cutanea Tarda (PCT)
2nd most common
pain, nausea, weakness
psych changes
measure porphobilinogen
Tx: Hemin
Acute Intermittent Porphyria (AIP)
most common in children
pain to sun-exposed skin w/in minutes
erythema, swelling
no blistering
measure erythrocyte total protoporphyrin
Erythropoietic porphyria (EPP)
donor cells see host a foreign → attack
common: skin, gut, liver
HLA most important thing to match
prevention is key
Tx: immunosuppressives
steroids
Graft vs Host Disease (GVHD)
adhere
activate
aggregate → platelet plug
Primary hemostasis
coagulation cascade activated
fibrinogen → fibrin
Secondary hemostasis
cross linking of fibrin
clot maturation
wound healing
Tertiary hemostasis
inc plt destruction, acquired
autoimmune, females > males
antibodies against plts
no apparent cause
mucocutaneous bleeding
acute seen in kids, chronic adults
Dx: exclusion
Labs: thrombocytopenia, PT/PTT normal, neg D-dimer, no schistocytes
Tx: IVIG, glucocorticoids (steroids), splenectomy
Immune Thrombocytic Purpura (ITP)
life-threatening
autoantibodies cross-react with plts
Heparin exposure
activated plts → hyper coagulable (both venous and arterial thrombosis)
Dx: sudden thrombocytopenia, HIT antibody +, PT/PTT normal
Tx: stop heparin, start non-hep anticoagulant (direct thrombin inhibitor) (argatroban), avoid plts
Heparin-Induced Thrombocytopenia (HIT)
inc von Willebrand Factor
fever, anemia (MAHA), thrombocytopenia, renal failure, neurologic changes
ADAMTS13 deficiency
factors falsely trigger platelet plug formation w/o injury
ischemia, organ failure, death
Labs: PT/PTT N, D-dimer negative, schistocytes
Tx: plasma exchange, glucocorticoids, Rituxan, caplacizumab
Thrombotic Thrombocytopenia Purpura (TTP)
heterogeneous group of disorders characterized by proliferation of 1+ cell line in the peripheral blood
Ex: polycythemia vera, essential thrombocythemia, CML
myeloproliferative neoplasm
clonal disorder w/ proliferation and maturation of erythoid, megakaryocytic, and granulocytic elements
Hb >16.5 F, > 18.5 M
Labs: inc H&H, potential inc WBC & plt, low EPO, JAK2 mutation
inc EPO → secondary
Sx due to poor oxygenation of tissues due to blood hyperviscosity
Tx: stem cell transplant, prevent event, ASA daily, therapeutic phlebotomy (removal of 400-500mL blood 1-2 x weekly until Oct <45%)
Polycythemia Vera
Labs: JAK2 mutation, high plts
Risks:
high: hx of thrombosis, >60 you w/ JAK2
intermediate: >60 yo, no JAK2, no hx thrombosis
low: <60yo, JAK2, no hx of thrombosis
very low: <60 yo, no JAK2, no hx of thrombosis
Sx: vasomotor, hemorrhagic, thrombotic, splenomegaly
Tx: ASA daily, hydroxyurea, tx underlying cause
Essential thrombocythemia
abn accumulation of iron → organ toxicity
most common inherited liver disease
most common cause of severe iron overload
heart, liver, pancreas, pituitary gland, joints, skin
men > women; Northern European origin
apparent later in life; women even later due to menses
“bronze diabetes” → skin pigmentation
HFE1 gene on chromosome 6; genetic testing
Sx: asymptomatic, low libido, darkening of skin
cirrhosis, abn liver function, liver cancer
Tx: lower iron: phlebotomy, chelation, avoid excessive intake
Hemochromatosis
Transfusions
obtain written consent
only given after careful evaluation
Whole Blood
whole blood minus plts
use has been replaced by PRBC infusions
used for large volume blood loss
RBC components
PRBCs
leukodepleted RBCs
Washed RBCs
frozen RBCs
irradiated red cells
CMV- cells
RBC transfusion
share of risk
used to improve O2 delivery, not treat hypovolemia
inc Hgb by 1
Platelets
treat thrombocytopenia
prevent bleeding
ex: pooled random donor plts
single donor pheresis plts
HLA-matched single donor plts
Coagulation Factors
FFP
massive blood loss
ER reversal of warfarin
DIC
Cryoprecipitate
Factor 8 deficiency
fibrinogen replacement
DIC
Purified and recombinant factor preps
inherited factor deficiencies
Transfusion Complications
hemolytic reactions
febrile reactions
allergic reactions
infectious agent transmission
Transfusion Reaction Hemolysis
fever, chills, chest pain, hypotension
imending doom
STOP transfusions immediately
Transfusion of mismatched blood can be FATAL
x-linked recessive = males
most common Hemophilia
deficiency in Factor 8, intrinsic pathway
hemarthrosis
Labs: PT, PTT inc, Factor 8 assay low
Tx: Factor 8 infusions, DDAVP (only for this one)
Hemophilia A
Christmas disease; Factor 9 deficiency
x-linked = males, Jews, milder
hemarthrosis
Labs: PT N, prolonged PTT, factor 9 assay low
Tx: factor 9 infusion, antifibrionolytics
Hemophilia B
Labs: inc PT/PTT, inc liver enzymes, dec Vit K, factors 2, 7, 9, 10
Tx: underlying disorder, parenteral infusion, FFP for hemorrhage
Vit K deficiency
most common inherited bleeding disorder
autosomal dominant M=F
mucocutaneous bleeding
Labs: assays, RIPA, PT N, inc PTT, vWF antibody low
Tx: DDAVP (T1), vWF concentrates (T2 & 3)
von Willebrand Deficiency
ongoing coagulation and fibrinolysis
production of thrombi, blood oozing form wounds
very sick pts
Labs: thrombocytopenia, inc D-dimer, inc PT/PTT, low fibrinogen, schistocytes, dec Protein C
Tx: supportive, cryoprecipitate for low fibrinogen, anticoagulation if hypercoagulative, wait
Desseminated Intravascular Coagulation (DIC)
preeclampltic, eclamtic
intravascular hemolysis
elevated liver enzymes
low plt count
third trimester, epigastric/RUQ pain, nausea/vomiting
HELLP Syndrome
much less neurologic sx, more likely renal failure
E. coli 0157:57
bloody diarrhea, renal failure
thrombocytopenia, MAHA, AKI
Labs: Serum Cr inc significantly
Tx: supportive, hemodialysis
inc mortality in older children and adults
Hemolytic Uremic Syndrome (HUS)
most common VTE
5x more deaths than breast cancer
unilateral
DVT
SOB
tachypneic
chest pain
hemoptysis
PE
Vit K dependent, autosomal inherited
homozygous → neonatal purpura, DIC
hypercoagulabe state
VTE, warfarin induced necrosis
Labs: protein assay
Tx: anticoagulation
Protein C & S Deficiency
most common inheritable clotting disorder
hypercoagulable state
VTE, miscarriages
Labs: genetic testing, Protein C resistance assay
Tx: anti coagulation
Factor V Leiden